Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new publication citation was added to the Publications section, detailing a 2024 Oncologist article on selpercatinib's long-term safety and related RET-activated tumors.SummaryDifference0.0%

- Check19 days agoChange DetectedClinicalTrials.gov’s study details page now reflects a newer software/content release revision (v3.5.3 instead of v3.5.2), without changing any study-specific information.SummaryDifference0.0%

- Check26 days agoChange DetectedResults status changed from 'Results Submitted' (2025-10-20) to 'Results Posted' (2026-04-16), with added text describing the LIBRETTO-001 trial results and phase 2 cohorts. The update indicates public availability of the study results and related documentation.SummaryDifference6%

- Check47 days agoChange DetectedMedullary thyroid carcinoma term added to the study conditions. Genetic and Rare Diseases Information Center resources added.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.5.0; Revision: v3.4.3 removed. The update appears to be an internal version bump with no visible changes to the study page content in the provided screenshots.SummaryDifference0.0%

- Check70 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.